poisar

Stocks · News reference

West Pharmaceutical Services shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates. Also, the company raised its FY26 guidance above estimates.

Jul 23, 2026, 12:45 PMBenzinga Newsdesk
Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

WST
Source
benzinga
Observed
Jul 23, 2026, 12:45 PM
Checked
Jul 23, 2026, 12:45 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 27, 2026, 3:31 PMNa

    Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up

    Veeva Systems (VEEV) reported Q2 fiscal 2027 adjusted EPS of $2.35, up 18.1% YoY and beating consensus by 5.9%, with revenues rising 17.6% to $928 million. The company raised its fiscal 2027 revenue guidance to $3.682-$3.687 billion and EPS to $9.21. Vault CRM momentum continued with over 180 customers live including five top 20 biopharmas, while the company advanced its AI strategy with Veeva Falcon.

    Read original at zacks-investment-research
    VEEVGMEDWSTCOO